Coordinated Vulnerability Disclosure (CVD) Process
PRODUCT SECURITY AND COORDINATED VULNERABILITY DISCLOSURE PROCESS FOR DIAGNOSTIC PRODUCTS
At Leica Biosystems, we develop technologies to advance and optimize the laboratory. To achieve this, we uphold core values that define our responsibility to those we serve. Among them: an unwavering commitment to the safety and security of patients and laboratory personnel. Therefore, we believe in continuously improving to address the ever-evolving privacy and cybersecurity landscape.
In response to potential threats to cybersecurity, Leica Biosystems is part of a global product security team to assess vulnerabilities and determine responses within a Coordinated Vulnerability Disclosure (CVD) process. These efforts allow the company to continually learn from vulnerability test information submitted to us by customers and security researchers.
For the latest product detail information, please visit product security updates tab.